Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients

The Pharmacogenomics Journal, Published online: 10 December 2019; doi:10.1038/s41397-019-0139-4Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients

https://www.nature.com/articles/s41397-019-0139-4

Source: The Pharmacogenomics Journal - December 9, 2019 Category: Drugs & Pharmacology Authors: Stephanie F. Ling Nisha Nair Suzanne M. M. Verstappen Anne Barton Hans-Dieter Zucht Petra Budde Peter Schulz-Knappe Darren Plant Source Type: research